Emcure Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue2,2732,3652,4742,5832,824
Expenses1,9322,0132,1432,1892,378
EBITDA478.60494.60483.55534.57591.09
EBIT373.96351.77387.58425.07481.43
Profit Before Tax341.42313.79341.18393.52445.85
Net Profit251.37231.37243.74292.49325.07
Financial Ratios
Operating Profit Margin21.09%19.31%20.00%20.72%20.96%
Net Profit Margin10.73%10.84%9.57%11.39%11.54%
Earning Per Share (Diluted)12.8512.1612.8415.5017.14
Dividends Per Share0.000.000.000.000.00